Application Note: Rapid identification and development of SARS-CoV-2 selective Optimers™
3 March 2021

In this application note, Aptamer Group outlines its high-affinity Optimer reagents for SARS-CoV-2 S1, S2, and nucleocapsid (NC) viral target proteins which promise to improve ELISA performance compared to commercially available antibodies.